These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1929099)

  • 1. [Climacteric syndrome: comparison of several secondary therapies].
    Bianco V; Colombo A; Tassan Simonat P
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):54-60. PubMed ID: 1929099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
    Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    Garcia de Arriba S; Grüntkemeier L; Häuser M; May TW; Masur C; Stute P
    PLoS One; 2022; 17(5):e0266633. PubMed ID: 35551533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical therapy of postmenopausal dyspareunia].
    Grio R; Mazza O; Cellura A; Zaccheo F; Giobbe C; Marchino GL; Malara D
    Minerva Ginecol; 1988 Dec; 40(12):695-7. PubMed ID: 3244441
    [No Abstract]   [Full Text] [Related]  

  • 6. Trazodone: a non-hormonal alternative for neurovegetative climacteric symptoms.
    Pansini F; Albertazzi P; Bonaccorsi G; Zanotti L; Porto S; Dossi L; Campobasso C; Mollica G
    Clin Exp Obstet Gynecol; 1995; 22(4):341-4. PubMed ID: 8777792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The alternative to hormonal treatment of menopausal vasomotor flushes: veralipride].
    Wesel S; Bosuma WB
    Sem Hop; 1983 Mar; 59(9):596-9. PubMed ID: 6304907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
    Delanian L
    Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veralipride: alternative antidopaminergic treatment for menopausal symptoms.
    David A; Don R; Tajchner G; Weissglas L
    Am J Obstet Gynecol; 1988 May; 158(5):1107-15. PubMed ID: 2967034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of menopausal hot flushes with a nonhormonal medication, veralipride].
    Marzolf G; Eberst B; Aerts A; Lecornu C; Mark J; Gandar R
    Sem Hop; 1982 Nov; 58(41):2382-4. PubMed ID: 6297023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of an novel molecule, veralipride, in the treatment of menopausal disorders].
    Grall JY
    Sem Hop; 1982 Nov; 58(43):2535-7. PubMed ID: 6297046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule?
    Murina F; Graziottin A; Felice R; Di Francesco S
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():121-124. PubMed ID: 27838536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses.
    Bottiglione F; Volpe A; Esposito G; Aloysio DD
    Maturitas; 1995 Nov; 22(3):227-32. PubMed ID: 8746880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial].
    Bazin S; Lefebvre J; Fortier M; Brisson J; Brouillette F; Bujold E; Bouchard C
    J Obstet Gynaecol Can; 2011 Aug; 33(8):838-843. PubMed ID: 21846439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
    Wesel S; Bourguignon RP; Bosuma WB
    Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience].
    Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E
    Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of estriol depot vaginal suppositories in postmenopausal women with urogenital climacteric manifestations].
    Köchli OR; Schär G; Beck B; Benz J
    Gynakol Geburtshilfliche Rundsch; 1992; 32(2):88-91. PubMed ID: 1392633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].
    Renaud R; Macler J
    Sem Hop; 1981 Feb 18-25; 57(7-8):353-5. PubMed ID: 6261369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.